Bo-Tao Xin

Bo-Tao Xin has a strong background in scientific research, having worked in various roles and companies throughout their career. Bo-Tao started as a PhD student at Leiden University in 2012, focusing on their research until their completion in 2016. Bo-Tao then moved on to become a Postdoctoral Researcher at Leiden University Medical Center, where they worked on developing novel proteasome inhibitors and reagents related to the Ubiquitin Proteasome System. In 2021, they transitioned to QPS Netherlands B.V. as a Scientist, specializing in large molecule LC-MS/Bioanalysis and drug metabolism. After a year, they joined SeraNovo in 2022 as a Scientist, working until 2023. Currently, Bo-Tao Xin is employed at TRISKELION as a Project Manager and Study Director.

Bo-Tao Xin pursued their higher education at Leiden University, where they graduated with a Doctor of Philosophy (PhD) degree in Chemical Biology. Bo-Tao attended the university from 2012 to 2016.